dehydroepiandrosterone sulfate has been researched along with Disease Exacerbation in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 12 (52.17) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brac de la Perriere, A; Chau, D; Guignat, L; Jacquez, A; Morel, Y; Nicolino, M; Pugeat, M; Raverot, G; Roucher-Boulez, F; Vial, C | 1 |
| Nasir, A; Raeisi, D; Shafeizadeh, S; Sherkatolabbasieh, H; Zare, ME | 1 |
| Alsinnawi, M; Balk, S; Bianchi-Frias, D; Burns, J; Cho, E; Montgomery, RB; Mostaghel, EA; Nelson, PS; Porter, C; Slee, AE; Sowalsky, A; Taplin, ME; True, L; Ye, H; Zhang, A; Zhang, X | 1 |
| Banasiak, W; Biel, B; Jankowska, EA; Katkowski, B; Maj, J; Ponikowska, B; Ponikowski, P; Rydlewska, A | 1 |
| Agus, DB; Bargfrede, M; Carthon, B; Clark, WR; Gandhi, JG; Heath, E; Kong, N; Lin, J; Liu, G; Moran, S; Oh, WK; Petrylak, DP; Suri, A | 1 |
| Harshman, LC; Kantoff, AM; Kantoff, PW; Lee, GS; Mucci, LA; Nakabayashi, M; Pomerantz, M; Sweeney, CJ; Valenca, L; Wang, X; Werner, L; Xie, W; Yu, Y | 1 |
| Chittiprol, S; Desai, A; Kumar, AM; Kumar, HR; Kumar, M; Philip, M; Rao, RS; Ravi, V; Satish, KS; Satishchandra, P; Shetty, KT; Subbakrishna, DK | 1 |
| Balk, S; Brown, M; Figg, WD; Freedman, M; Kantoff, PW; Lee, GS; Mostaghel, E; Nakabayashi, M; Oh, WK; Pomerantz, M; Regan, M; Ross, R; Sharifi, N; Sun, T; Taplin, ME; Werner, L; Xie, W; Yang, M | 1 |
| Hafström, I; Tengstrand, B | 1 |
| Calhoun, K; Cheek, J; Fletcher, W; Pommier, R; Toth-Fejel, S | 1 |
| Arleth, S; Bechtold, S; Bittmann, I; Bonfig, W; Kammer, B; Noelle, V; Raile, K; Schwarz, HP | 1 |
| Hardin, C; Jackson, T; Lefleur, B; Pommier, R; Toth-Fejel, S | 1 |
| Cygankiewicz, I; Kula, K; Kula, P; Rosiak, M; Wranicz, JK; Zareba, W | 1 |
| Allerup, P; Eller, NH; Netterstrøm, B | 1 |
| Eis, V; Hampl, R; Heracek, J; Kuncova, J; Mandys, V; Sachova, J; Starka, L; Urban, M | 1 |
| Abraham, OC; Ebenezer, DL; Job, V; Kandathil, AJ; Kannangai, R; Mathai, E; Prakash, AJ; Pulimood, SA; Selvakumar, R; Sridharan, G; Sudarsanam, TD | 1 |
| Araneo, BA; Harrison, LL; Norton, SD; Yowell, R | 1 |
| Boers, M; Dijkmans, BA; Giltay, EJ; Gooren, LJ; Popp-Snijders, C; van Schaardenburg, D; Verhoeven, AC | 1 |
| Antoni, MH; Cruess, DG; Fernandez, JB; Fletcher, M; Ironson, G; Kumar, M; McCabe, P; Schneiderman, N | 1 |
| Ferrando, SJ; Poretsky, L; Rabkin, JG | 1 |
| Demeter, L; Evans, T; Fitzgerald, T; Kieburtz, K; McDermott, MP; Schifitto, G; Schwimmer, J | 1 |
| Baghdadi, A; Damian, RT; Mohamed, F; Morales-Montor, J; Newhouse, E | 1 |
| Baulieu, EE; Debuire, B; Gonzalez-Canali, G; Jayle, D; Kazatchkine, MD; Piketty, C | 1 |
5 trial(s) available for dehydroepiandrosterone sulfate and Disease Exacerbation
| Article | Year |
|---|---|
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dehydroepiandrosterone Sulfate; Disease Progression; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Humans; Imidazoles; Male; Middle Aged; Naphthalenes; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Steroid 17-alpha-Hydroxylase; Taxoids; Testosterone | 2015 |
HIV-1 clade C infection and progressive disruption in the relationship between cortisol, DHEAS and CD4 cell numbers: a two-year follow-up study.
Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dehydroepiandrosterone Sulfate; Disease Progression; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Hydrocortisone; Male; Middle Aged; Neurosecretory Systems; Sex Characteristics; Young Adult | 2009 |
Progression in intima media thickness--the significance of hormonal biomarkers of chronic stress.
Topics: Adult; Analysis of Variance; Arteriosclerosis; Biomarkers; Carotid Artery, Common; Chronic Disease; Circadian Rhythm; Dehydroepiandrosterone Sulfate; Disease Progression; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Reference Values; Regression Analysis; Risk Factors; Saliva; Severity of Illness Index; Sex Factors; Stress, Psychological; Testosterone; Tunica Intima; Tunica Media; Ultrasonography | 2005 |
Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men.
Topics: Adolescent; Adult; Arousal; Dehydroepiandrosterone Sulfate; Depression; Disease Progression; HIV Seropositivity; Humans; Hydrocortisone; Male; Middle Aged; Sick Role | 1999 |
Autonomic performance and dehydroepiandrosterone sulfate levels in HIV-1-infected individuals: relationship to TH1 and TH2 cytokine profile.
Topics: Adult; Autonomic Nervous System; beta 2-Microglobulin; CD4 Lymphocyte Count; Cognition Disorders; Dehydroepiandrosterone Sulfate; Disease Progression; Female; Heart Rate; HIV Infections; Humans; Interferon-gamma; Interleukin-4; Male; Polyneuropathies; Regression Analysis; Respiration; Th1 Cells; Th2 Cells; Viral Load | 2000 |
18 other study(ies) available for dehydroepiandrosterone sulfate and Disease Exacerbation
| Article | Year |
|---|---|
Triple-A syndrome: a wide spectrum of adrenal dysfunction.
Topics: Adolescent; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Child; Cognition Disorders; Cohort Studies; Dehydroepiandrosterone Sulfate; Disease Progression; Esophageal Achalasia; Female; France; Glucocorticoids; Humans; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Pore Complex Proteins; Peripheral Nervous System Diseases; Phenotype; Prognosis; Renin; Retrospective Studies; Young Adult; Zona Fasciculata; Zona Reticularis | 2018 |
Sex Hormones and Prolactin Levels and Their Association with Anti Cardiolipin Antibody in Patients with Systemic Lupus Erythematosus.
Topics: Adult; Antibodies, Anticardiolipin; Dehydroepiandrosterone Sulfate; Disease Progression; Estradiol; Female; Humans; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Progesterone; Prolactin; Testosterone; Young Adult | 2018 |
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy.
Topics: Adult; Aged; Androgen Antagonists; Androstenes; Dehydroepiandrosterone Sulfate; Disease Progression; Docetaxel; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Grading; Organic Anion Transporters; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms, Castration-Resistant; Solute Carrier Organic Anion Transporter Family Member 1B3; Testosterone; Treatment Outcome | 2019 |
Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure.
Topics: Age Factors; Aged; Autonomic Nervous System Diseases; Baroreflex; Blood Chemical Analysis; Cohort Studies; Dehydroepiandrosterone Sulfate; Disease Progression; Estradiol; Heart Failure, Systolic; Humans; Male; Middle Aged; Postural Balance; Prognosis; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Testosterone | 2013 |
Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Chi-Square Distribution; Dehydroepiandrosterone Sulfate; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multivariate Analysis; Neoplasms, Hormone-Dependent; Organic Anion Transporters; Proportional Hazards Models; Prostatic Neoplasms; Retrospective Studies; Risk Factors; RNA Interference; Time Factors; Transfection; Treatment Outcome | 2015 |
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Biological Transport; Dehydroepiandrosterone Sulfate; Disease Progression; Disease-Free Survival; DNA Mutational Analysis; Drug Resistance, Neoplasm; Genotype; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Hormone-Dependent; Orchiectomy; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Solute Carrier Organic Anion Transporter Family Member 1B3; Testosterone | 2011 |
Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones.
Topics: Absorptiometry, Photon; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Bone and Bones; Bone Density; Dehydroepiandrosterone Sulfate; Disability Evaluation; Disease Progression; Estradiol; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Sex Factors; Sulfasalazine; Surveys and Questionnaires; Testosterone | 2002 |
The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression.
Topics: Adult; Age Factors; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Dehydroepiandrosterone Sulfate; Disease Progression; Drug Resistance; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Retrospective Studies; Risk Factors; Tamoxifen; Tumor Cells, Cultured | 2003 |
Virilising adrenocortical tumours in children.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; Adrenocortical Carcinoma; Adrenocorticotropic Hormone; Androstenedione; Biomarkers; Child; Child, Preschool; Dehydroepiandrosterone Sulfate; Diagnostic Errors; Disease Progression; Female; Humans; Immunohistochemistry; Infant; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Mutation; Testosterone; Tomography, X-Ray Computed; Tumor Suppressor Protein p53; Ultrasonography, Interventional; Virilism | 2003 |
Understanding the biologic mechanisms responsible for breast-cancer progression during tamoxifen or fulvestrant treatment.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Disease Progression; Estradiol; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Tamoxifen; Treatment Failure; Tumor Cells, Cultured | 2004 |
The relationship between sex hormones and lipid profile in men with coronary artery disease.
Topics: Adult; Aged; Coronary Artery Disease; Dehydroepiandrosterone Sulfate; Disease Progression; Epidemiologic Studies; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Lipoproteins; Male; Middle Aged; Poland; Risk Factors; Sex Distribution; Testosterone | 2005 |
The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy.
Topics: Aged; Dehydroepiandrosterone Sulfate; Disease Progression; Estradiol; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Prognosis; Prolactin; Prostatectomy; Prostatic Neoplasms | 2007 |
Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Biomarkers; C-Reactive Protein; CD4-Positive T-Lymphocytes; Dehydroepiandrosterone Sulfate; Developing Countries; Disease Progression; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Prognosis; Serum Albumin; Viral Load | 2008 |
Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice.
Topics: Age Factors; Animals; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; B-Lymphocyte Subsets; Dehydroepiandrosterone Sulfate; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunoglobulin M; Interleukin-10; Mice; Mice, Inbred NZB; Phosphatidylcholines | 1997 |
Serum dehydroepiandrosterone sulphate levels in patients with early rheumatoid arthritis: positive association with C-reactive protein, but not with HLA-DR genotype.
Topics: Adult; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Dehydroepiandrosterone Sulfate; Disease Progression; Female; HLA-DR Antigens; Humans; Male; Middle Aged; Predictive Value of Tests; Treatment Outcome | 1998 |
Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year.
Topics: Adult; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Depressive Disorder; Disease Progression; Drug Therapy, Combination; Fatigue; HIV Infections; Humans; Male; Reverse Transcriptase Inhibitors; Severity of Illness Index; Testosterone; Viral Load | 1999 |
Altered levels of hypothalamic-pituitary-adrenocortical axis hormones in baboons and mice during the course of infection with Schistosoma mansoni.
Topics: Adrenocorticotropic Hormone; Animals; Corticotropin-Releasing Hormone; Dehydroepiandrosterone Sulfate; Disease Models, Animal; Disease Progression; Female; Hydrocortisone; Hypothalamo-Hypophyseal System; Liver; Mice; Mice, Inbred C57BL; Papio; Parasite Egg Count; Pituitary-Adrenal System; Schistosoma mansoni; Schistosomiasis mansoni | 2001 |
Low plasma levels of dehydroepiandrosterone (DHEA) and incidence of lipodystrophy.
Topics: Adult; Antiretroviral Therapy, Highly Active; Biological Availability; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dietary Supplements; Disease Progression; Female; HIV Infections; Humans; Incidence; Lipodystrophy; Male; Risk Factors; Safety; Treatment Outcome | 2001 |